With strong in-house design services that offer innovative designs for medical devices such as autoinjectors, pen injectors, and inhalers, SHL has successfully introduced numerous next-generation devices to the industry.
Menu
The primary objective for SHL Connect is to investigate the market for connectivity and emerging technologies and explore their potential application within each of SHL Group’s companies.
The necessity for autoinjector has been growing rapidly over the years, spurring a variety of innovative designs to meet patient needs and to differentiate amongst the industry.
As the prevalence of chronic diseases rises and the emergence of biologics grow, the demand for self-administered drug delivery devices like autoinjectors and pen injectors continues to increase rapidly
To encourage staff donation and further express the company’s commitment, SHL has pledged to match the final amount donated by SHL employees.
